trending Market Intelligence /marketintelligence/en/news-insights/trending/um2lCe-wmZdbKkKhg4FuAg2 content esgSubNav
In This List

Innovus Pharmaceuticals undertaking 1-for-105 reverse stock split

Blog

Insight Weekly: Bank boards lag on gender parity; future of office in doubt; US LNG exports leap

Blog

Insight Weekly: Job growth faces hurdles; shale firms sit on cash pile; Africa's lithium future

Blog

Insight Weekly: Loan growth picks up; US-China PE deals fall; France faces winter energy crunch

Blog

Perspectives from China: Chinese M&A in 2022


Innovus Pharmaceuticals undertaking 1-for-105 reverse stock split

Innovus Pharmaceuticals Inc. is implementing a 1-for-105 reverse split of its common stock.

The San Diego-based pharmaceutical company said its stock will begin trading on a split-adjusted basis on the OTCQB marketplace at the opening of trading March 18.

The reverse stock split was approved by a majority of Innovus' stockholders Feb. 22.